| | Identification | Back Directory |  | [Name] 
 MITOQ
 |  | [CAS] 
 444890-41-9
 |  | [Synonyms] 
 MitoQ10
 Mitoquinol(MITOQ)
 Mitoquinone
Discontinued
 Mitoquinone | Mitochondria-targeted antioxidant
 |  | [Molecular Formula] 
 C37H44O4P+
 |  | [MDL Number] 
 MFCD27977560
 |  | [MOL File] 
 444890-41-9.mol
 |  | [Molecular Weight] 
 583.73
 | 
 | Chemical Properties | Back Directory |  | [storage temp. ] 
 -20°
 |  | [solubility ] 
 Soluble in DMSO (70 mg/mL); ethanol (30 mg/mL)
 |  | [form ] 
 waxy solid
 |  | [color ] 
 Brown
 |  | [Stability:] 
 Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months.
 | 
 | Hazard Information | Back Directory |  | [Description] 
 Mitoquinone (444890-40-9) is a mitochondria-targeted antioxidant. Displays cardio- and neuroprotective effects.1?Displays beneficial effects in mouse models of Alzheimer’s disease.2?Mitoquinone protects pancreatic β-cells against oxidative stress and improves insulin secretion.3 Cell permeable.? Mesylate salt (Cat# 10-3914)and mesylate cyclodextrin complex (Cat# 10-3915) are also available.
 |  | [Uses] 
 Mitoquinone is a mitochondria-targeted antioxidant.
 |  | [References] 
 1) Ghosh et al. (2010), Neuroprotection by a mitochondria-targeted drug in a Parkinson’s disease model; Free Radic. Biol. Med., 49 1674
2) McManus et al. (2011), The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease; J. Neurosci., 31 15703
3) Lim et al. (2011), Mitochondria-targeted antioxidants protect pancreatic β-cells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicity; Cell Physiol. Biochem., 28 873
4) Demers-Lamarche et al. (2016) Loss of Mitochondrial Function Impairs Lysosomes; J. Biol. Chem. 291 10263 [Focus Citation]
5) Zhou et al. (2018) Mitochondrial-targeted antioxidant MitoQ provides neuroprotection and reduces neuronal apoptosis in experimental traumatic brain injury possibly via the Nrf2-ARE pathway; Am. J. Transl. Res., 10 1887 [Focus Citation]
6) Xiao et al. (2017) The mitochondrial-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1; Redox Biol., 11 297 [Focus Citation]
7) Deng et al. (2019), Myo-inositol oxygenase expression profile modulates pathogenic ferroptosis in the renal proximal tubule; J. Clin. Invest., 129 5033 [Focus Citation]
 | 
 | 
                    
                        
                            | Company Name: | InvivoChem |  
                            | Tel: | 13549236410 |  
                            | Website: | https://www.invivochem.cn/ |  |